central
nervou
system
cn
infect
multipl
potenti
caus
agent
simultan
pathogen
screen
provid
use
tool
studi
evalu
multiplex
microarray
simultan
detect
antibodi
cn
pathogen
perform
select
microarray
antigen
detect
igg
antibodi
herp
simplex
viru
varicellazost
viru
vzv
adenoviru
mycoplasma
pneumonia
borrelia
burgdorferi
sensu
lato
evalu
use
serum
sampl
panel
test
refer
assay
use
routin
diagnost
laboratori
microarray
sensit
vzv
adenoviru
pneumonia
rang
specif
rang
variabl
sensit
specif
found
borreli
antigen
three
differ
vlse
protein
ir
peptid
variant
three
recombin
decorin
bind
protein
dbpa
dbpaia
singl
antigen
good
specif
shown
antigen
dbpaia
moder
specif
analyt
sensit
microarray
depend
borreli
igg
concentr
specimen
overal
perform
technic
featur
platform
show
platform
support
recombin
protein
whole
virus
peptid
antigen
studi
show
diagnost
potenti
six
cn
pathogen
includ
borrelia
burgdorferi
sensu
lato
use
glutaraldehyd
base
microarray
highlight
import
care
antigen
select
requir
use
multipl
borreli
antigen
order
increas
specif
without
major
lack
sensit
one
challeng
laboratori
diagnosi
central
nervou
system
cn
infect
rel
high
number
potenti
caus
pathogen
includ
eg
herp
simplex
viru
varicella
zoster
viru
vzv
borrelia
burgdorferi
sensu
lato
mycoplasma
pneumonia
nucleic
acid
detect
cerebrospin
fluid
csf
usual
method
choic
diagnosi
neuroinvas
viru
infect
especi
differ
herp
virus
howev
viru
serolog
serum
csf
provid
complementari
inform
play
import
role
particularli
prolong
infect
investig
longterm
sequela
neuroinvas
pneumonia
infect
nucleic
acid
detect
serolog
gener
use
serolog
sensit
neuroborreliosi
howev
serodiagnosi
borrelia
burgdorferi
sensu
lato
gener
complic
variabl
antibodi
respons
observ
individu
differ
stage
diseas
furthermor
borreli
antibodi
respons
may
reflect
infect
mere
contact
tick
carri
pathogen
due
complex
natur
borreliosi
sever
differ
diagnost
method
eg
enzym
immunoassay
eia
immunoblot
often
use
parallel
obtain
specif
reliabl
result
diagnosi
lyme
borreliosi
addit
serodiagnosi
borreli
infect
gener
suggest
two
specif
antigen
react
patient
serum
establish
diagnosi
eia
commonli
use
platform
serodiagnosi
neuroinvas
infect
sometim
complement
eg
immunoblot
simultan
screen
antibodi
relev
viral
bacteri
target
provid
advantag
tool
diagnosi
cn
infect
serolog
platform
multiplex
format
offer
rapid
costeffect
clinic
comprehens
approach
platform
includ
multiplex
beadbas
immunoassay
multipl
antigen
microarray
allow
parallel
antibodi
detect
differ
multiplex
beadbas
immunoassay
develop
eg
detect
antibodi
influenza
viru
streptococcu
pneumonia
lyme
borreliosi
pneumococc
meningococc
haemophilu
polysaccharid
tetanu
diphtheria
toxoid
yan
et
al
yu
et
al
whitelegg
et
al
gerritzen
brandt
multiplex
serolog
microarray
develop
eg
simultan
detect
hiv
coinfect
lochhead
et
al
well
diagnost
atyp
pneumonia
gouriet
et
al
detect
cn
pathogen
previou
microarray
design
focus
viral
nucleic
acid
detect
et
al
et
al
levequ
et
al
mannonen
et
al
detect
herpesviru
rubella
viru
toxoplasma
gondii
antibodi
use
nitrocellulos
base
aminosilan
activ
glass
microarray
protein
antigen
bacaresehamilton
et
al
et
al
proteom
microarray
set
profil
immun
respons
borrelia
burgdorferi
sensu
lato
xu
et
al
serolog
nucleic
acid
base
microarray
describ
earlier
diagnosi
lyme
borreliosi
aim
find
suitabl
microarray
platform
support
differ
kind
antigen
protein
detect
viral
bacteri
antibodi
set
microarray
detect
antibodi
borrelia
burgdorferi
sensu
lato
diagnosi
lyme
borreliosi
addit
aim
evalu
feasibl
multiplex
serolog
glutaraldehyd
base
microarray
platform
comprehens
diagnost
cn
infect
especi
vzv
adenoviru
pneumonia
use
serum
sampl
glutaraldehyd
coat
microtit
plate
base
microarray
viitala
et
al
set
use
differ
type
antigen
ie
recombin
protein
inactiv
virus
peptid
evalu
simultan
detect
antibodi
vzv
adenoviru
pneumonia
borrelia
burgdorferi
sensu
lato
clinic
serum
specimen
compar
commerci
refer
assay
igg
igg
elisa
kit
focu
diagnost
inc
cypress
ca
usa
use
hsv
antibodi
detect
mycoplasma
pneumonia
igg
eia
ani
labsystem
ltd
vantaa
finland
use
pneumonia
antibodi
detect
borrelia
afzelii
vlse
igg
elisa
kit
sekisui
virotech
gmbh
borrelia
igg
diasorin
borrelia
europ
plu
line
igg
line
immunoblot
sekisui
virotech
gmbh
germani
use
detect
borreli
igg
linear
measur
rang
auml
sekisui
virotech
test
veml
diasorin
test
posit
reaction
immunoblot
requir
distinct
reaction
least
two
antigen
includ
assay
ospc
vlsemix
dbpa
test
perform
accord
manufactur
instruct
valid
accredit
inhous
sandwicheia
huslab
finland
vzv
glycoprotein
eia
antigen
institut
virion
ltd
switzerland
inhous
adenoviru
eia
huslab
finland
inactiv
whole
adenoviru
antigen
use
vzv
adenoviru
igg
detect
respect
short
inhous
adenoviru
igg
eia
carri
use
microtit
plate
coat
attenu
adenoviru
strain
antigen
huslab
finland
follow
block
bovin
serum
albumin
bsa
jackson
immunoresearch
europ
ltd
suffolk
uk
serum
sampl
dilut
phosphat
buffer
salin
pb
contain
tween
pbst
incub
h
follow
three
wash
pbst
rabbit
antihuman
igg
conjug
hors
radish
peroxidas
hrp
dako
helsinki
finland
dilut
use
h
conjug
liquid
substrat
sigmaaldrich
use
colour
reaction
wash
three
time
pbst
min
incub
rt
colour
reaction
stop
h
absorb
read
nm
multiscan
rc
labsystem
finland
studi
materi
includ
serum
sampl
individu
patient
test
igg
antibodi
follow
antigen
routin
diagnost
helsinki
univers
central
hospit
laboratori
huslab
finland
n
n
vzv
n
adenoviru
n
pneumonia
n
borrelia
burgdorferi
sensu
lato
n
sera
test
vzv
adenoviru
pneumonia
igg
antibodi
deem
either
posit
neg
use
respect
refer
method
sera
deem
posit
borrelia
igg
n
reactiv
two
differ
eia
test
sekisui
virotech
diasorin
igg
immunoblot
sera
deem
neg
borrelia
igg
n
nonreact
one
eia
test
sekisui
virotech
order
better
evalu
analyt
sensit
microarray
reactiv
borreli
specimen
divid
three
subcategori
accord
igg
antibodi
concentr
follow
low
igg
concentr
n
intermedi
igg
concentr
n
high
igg
concentr
n
sum
numer
valu
two
eia
test
sekisui
virotech
diasorin
use
categor
low
igg
concentr
intermedi
high
singl
antigen
vzv
adenoviru
pneumonia
use
simultan
screen
specif
igg
antibodi
antigen
use
microarray
follow
recombin
glycoprotein
g
gg
amino
acid
acri
antibodi
gmbh
herford
germani
recombin
glycoprotein
g
gg
amino
acid
fuse
human
superoxid
dismutas
sod
acri
antibodi
gmbh
herford
germani
purifi
whole
viru
antigen
attenu
adenoviru
strain
huslab
finland
pneumonia
ag
ani
biotech
oy
vantaa
finland
recombin
vzv
ge
univers
gothenburg
gothenburg
sweden
recombin
vzv
ge
antigen
produc
mammalian
cell
larg
scale
known
specif
vzv
show
crossreact
hsv
grahn
et
al
complex
natur
immun
respons
borrelia
burgdorferi
sensu
lato
infect
requir
use
multipl
serolog
assay
increas
diagnost
sensit
specif
bacon
et
al
porwanch
porwanch
et
al
mind
six
antigen
borrelia
select
microarray
three
differ
vlse
protein
peptid
variant
core
facil
protein
chemistri
haartman
institut
univers
helsinki
helsinki
finland
et
al
prior
spot
pneumonia
six
borreli
antigen
dilut
spot
buffer
mmoll
nahco
ph
final
concentr
mgml
vzv
adenoviru
antigen
dilut
final
concentr
polystyren
plate
activ
prepolymer
glutaraldehyd
well
spot
viral
bacteri
antigen
triplic
use
biorobot
microgrid
ii
microarray
printer
biorobot
cambridg
uk
previous
describ
viitala
et
al
human
igg
hplc
purifi
sigmaaldrich
helsinki
finland
spot
triplic
use
posit
control
microarray
spot
buffer
rabbit
myosin
sigmaaldrich
includ
neg
control
summari
spot
polystyren
plate
well
one
well
use
per
serum
sampl
simultan
parallel
screen
differ
viral
bacteri
antibodi
antigen
spot
microarray
block
pb
contain
bsa
jackson
immunoresearch
europ
ltd
min
follow
three
wash
pb
contain
tween
block
microarray
dri
store
prior
use
serum
sampl
volum
dilut
bsa
jackson
immunoresearch
europ
ltd
pb
incub
min
microarray
wash
three
time
peroxidas
conjug
affinipur
donkey
antihuman
igg
h
l
jackson
immunoresearch
europ
ltd
dilut
pb
inclub
microarray
min
microarray
wash
subject
chromogen
ep
hs
tmbma
sdt
stereospecif
detect
technolog
baesweil
germani
min
dri
follow
imag
imag
microarray
taken
invert
microscop
olympu
olympu
finland
oy
espoo
finland
use
olympu
digit
microscop
camera
olympu
finland
oy
one
microarray
imag
consist
spot
spot
intens
antigen
local
background
signal
microarray
calcul
use
imagej
softwar
http
rsbwebnihgovij
cutoff
valu
determin
antigen
separ
use
five
nine
neg
serum
sampl
briefli
neg
serum
sampl
screen
triplic
analys
spot
intens
correct
background
signal
cutoff
valu
determin
antigen
multipli
mean
valu
intens
two
equivoc
rang
set
cutoff
intens
valu
serum
sampl
panel
test
parallel
serolog
microarray
refer
method
equivoc
intens
valu
microarray
interpret
neg
throughout
calcul
tabl
summar
perform
microarray
vzv
adenoviru
pneumonia
sensit
microarray
target
rang
specif
rang
overal
sensit
microarray
five
target
overal
specif
best
concord
compar
refer
test
observ
vzv
tabl
tabl
summar
perform
microarray
lyme
borreliosi
due
natur
microarray
techniqu
serorespons
detect
use
multipl
antigen
analys
use
differ
rule
set
see
whether
individu
antigen
antigen
combin
superior
other
detect
borreli
antibodi
first
specif
sensit
calcul
separ
borreli
antigen
assess
individu
perform
thereaft
perform
valu
calcul
select
antigen
combin
requir
simultan
reactiv
sensit
nonreact
specif
two
differ
antigen
final
perform
analys
three
borrelia
speci
separ
requir
reactiv
either
two
antigen
specif
speci
good
specif
shown
dbpaia
moder
specif
specif
poor
show
highest
sensit
sensit
dbpaia
respect
two
antigen
demonstr
best
overal
perform
b
burgdorferi
sensu
stricto
moder
specif
sensit
observ
sensit
b
afzelii
moder
poor
sensit
b
garinii
contrast
sensit
superior
specif
sampl
posit
borreli
igg
antibodi
divid
three
subcategori
low
intermedi
high
sensit
divers
differ
antigen
highest
sensit
valu
rang
found
among
sampl
show
high
concentr
borreli
igg
sensit
sampl
intermedi
igg
concentr
vari
among
low
igg
concentr
b
burgdorferi
sensu
lato
sampl
sensit
level
weak
higher
sensit
valu
found
dbpaia
antigen
microarray
techniqu
enabl
simultan
evalu
multipl
antigen
perform
select
antigen
valid
use
sampl
panel
test
select
refer
assay
studi
evalu
antigen
detect
igg
antibodi
import
cn
pathogen
name
vzv
adenoviru
pneumonia
speci
b
burgdorferi
sensu
stricto
predomin
speci
north
america
well
b
garinii
b
afzelii
predomin
eurasia
steer
qiu
et
al
hengg
et
al
buniki
et
al
caus
lyme
borreliosi
microarray
use
screen
purpos
bacaresehamilton
et
al
xu
et
al
et
al
lochhead
et
al
ardizzoni
et
al
viitala
et
al
appli
also
set
requir
enhanc
specif
recent
investig
exploit
microarray
platform
profil
immun
respons
borrelia
burgdorferi
sensu
lato
xu
et
al
anoth
influenza
virus
suggest
level
humor
immun
may
measur
tradit
hemagglutin
inhibit
assay
koopman
et
al
recent
similar
approach
appli
differ
coronavirus
reusken
et
al
earlier
demonstr
detect
viral
antibodi
quantit
creactiv
protein
feasibl
singl
microarray
viitala
et
al
microarray
techniqu
multipl
antigen
present
reaction
immunolog
histori
examin
simultan
sever
viral
bacteri
target
provid
opportun
comprehens
rapid
identif
caus
pathogen
sensit
specif
valu
develop
microarray
base
comparison
exist
refer
assay
refer
test
studi
use
larg
scale
routin
diagnost
laboratori
huslab
finland
consid
reliabl
test
platform
serum
sampl
reactiv
microarray
test
without
reaction
refer
test
eg
sampl
must
note
specimen
panel
repres
unbias
gener
popul
rather
individu
suspect
particular
infect
therefor
discord
sampl
may
truli
posit
respect
target
highlight
particularli
case
adenoviru
microarray
reactiv
posit
panel
sampl
sensit
neg
panel
specimen
whole
adenoviru
antigen
use
refer
assay
microarray
thu
superior
sensit
microarray
platform
plausibl
serodiagnosi
lyme
borreliosi
specif
critic
factor
reaction
sever
antigen
requir
determin
histori
borrelia
contact
microarray
develop
studi
six
borreli
antigen
use
result
singl
antigen
well
antigen
combin
evalu
demonstr
tabl
requir
simultan
reactiv
sensit
nonreact
specif
sever
antigen
consider
decreas
perform
valu
sensit
valu
artifici
increas
use
less
strict
rule
eg
requir
reactiv
one
two
antigen
repres
borrelia
speci
tabl
howev
subsequ
result
less
optim
specif
valu
reflect
requir
diagnost
laboratori
reli
singl
antigen
studi
highlight
import
care
select
diagnost
criteria
antigen
approach
adapt
clinic
use
diagnost
criteria
chosen
without
proper
valid
variabl
result
may
obtain
use
multipl
antigen
studi
two
antigen
site
vlse
dbpa
use
test
also
commerci
b
burgdorferi
recombin
protein
prospectani
technogen
ltd
rehovot
israel
b
afzelii
lysat
institut
virionserion
gmbh
germani
data
shown
antigen
prove
use
microarray
platform
dbpa
sequenc
site
high
interand
intraspeci
heterogen
consid
sensit
antigen
late
phase
lyme
borreliosi
particularli
neuroborreliosi
robert
et
al
et
al
et
al
b
schultespechtel
et
al
paneliu
et
al
use
sever
dbpa
antigen
differ
speci
may
increas
specif
sensit
microarray
assay
howev
dbpa
known
sensit
late
phase
lyme
borreliosi
antigen
differ
antigen
site
need
maintain
good
perform
microarray
assay
throughout
cours
ill
studi
demonstr
diagnost
potenti
multiplex
serolog
microarray
platform
detect
cn
pathogen
case
b
burgdorferi
sensu
lato
infect
specif
major
challeng
laboratori
diagnost
studi
highlight
requir
use
multipl
borreli
antigen
order
increas
specif
without
major
lack
sensit
overal
perform
platform
prove
promis
term
test
perform
technic
featur
requir
small
sampl
volum
potenti
adapt
also
csf
specimen
